Agile Therapeutics, Inc.

OTCPK:AGRX Stok Raporu

Piyasa değeri: US$10.4m

This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

Agile Therapeutics Yönetim

Yönetim kriter kontrolleri 4/4

Agile Therapeutics' CEO is Al Altomari, appointed in Oct 2010, has a tenure of 13.83 years. total yearly compensation is $788.72K, comprised of 76.1% salary and 23.9% bonuses, including company stock and options. directly owns 0.28% of the company’s shares, worth $29.63K. The average tenure of the management team and the board of directors is 4.6 years and 6.1 years respectively.

Anahtar bilgiler

Al Altomari

İcra Kurulu Başkanı

US$788.7k

Toplam tazminat

CEO maaş yüzdesi76.1%
CEO görev süresi13.8yrs
CEO sahipliği0.3%
Yönetim ortalama görev süresi4.6yrs
Yönetim Kurulu ortalama görev süresi6.1yrs

Son yönetim güncellemeleri

How Many Agile Therapeutics, Inc. (NASDAQ:AGRX) Shares Did Insiders Buy, In The Last Year?

Feb 25
How Many Agile Therapeutics, Inc. (NASDAQ:AGRX) Shares Did Insiders Buy, In The Last Year?

Recent updates

Agile appoints chief commercial officer from within ranks amid leadership revamp

Oct 10

Agile gains as H.C. Wainwright sees 630% upside potential

Jul 11

Agile Therapeutics prices $24M upsized stock offering

Jul 01

Agile Therapeutics: Twirla's Lackluster Launch Forces Me To Change My Strategy

Apr 04

Agile Therapeutics: Bullish On Capitulation And Max Pain

Oct 19

Agile Therapeutics: Another Quarter Of Progress And Another Opportunity To Buy

Jul 30

Agile Therapeutics, Inc. 2021 Q1 - Results - Earnings Call Presentation

May 06

How Many Agile Therapeutics, Inc. (NASDAQ:AGRX) Shares Did Insiders Buy, In The Last Year?

Feb 25
How Many Agile Therapeutics, Inc. (NASDAQ:AGRX) Shares Did Insiders Buy, In The Last Year?

Agile Therapeutics issues cash projection at JP Morgan healthcare conference

Jan 14

Assessing Agile Therapeutics

Jan 10

How Many Agile Therapeutics, Inc. (NASDAQ:AGRX) Shares Do Institutions Own?

Jan 04
How Many Agile Therapeutics, Inc. (NASDAQ:AGRX) Shares Do Institutions Own?

Agile Therapeutics announces peer-reviewed publication of late-stage study for Twirla contraception patch

Nov 30

Agile Therapeutics EPS in-line

Nov 12

CEO Tazminat Analizi

Al Altomari'un ücretlendirmesi Agile Therapeutics'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Jun 30 2024n/an/a

-US$16m

Mar 31 2024n/an/a

-US$8m

Dec 31 2023US$789kUS$601k

-US$14m

Sep 30 2023n/an/a

-US$14m

Jun 30 2023n/an/a

-US$19m

Mar 31 2023n/an/a

-US$20m

Dec 31 2022US$841kUS$601k

-US$25m

Sep 30 2022n/an/a

-US$41m

Jun 30 2022n/an/a

-US$52m

Mar 31 2022n/an/a

-US$64m

Dec 31 2021US$2mUS$594k

-US$71m

Sep 30 2021n/an/a

-US$69m

Jun 30 2021n/an/a

-US$68m

Mar 31 2021n/an/a

-US$61m

Dec 31 2020US$2mUS$555k

-US$52m

Sep 30 2020n/an/a

-US$40m

Jun 30 2020n/an/a

-US$29m

Mar 31 2020n/an/a

-US$22m

Dec 31 2019US$1mUS$507k

-US$19m

Sep 30 2019n/an/a

-US$16m

Jun 30 2019n/an/a

-US$16m

Mar 31 2019n/an/a

-US$18m

Dec 31 2018US$2mUS$494k

-US$20m

Sep 30 2018n/an/a

-US$22m

Jun 30 2018n/an/a

-US$26m

Mar 31 2018n/an/a

-US$28m

Dec 31 2017US$1mUS$492k

-US$28m

Tazminat ve Piyasa: Al's total compensation ($USD788.72K) is about average for companies of similar size in the US market ($USD666.73K).

Tazminat ve Kazançlar: Al's compensation has been consistent with company performance over the past year.


CEO

Al Altomari (65 yo)

13.8yrs

Görev süresi

US$788,718

Tazminat

Mr. Alfred F. Altomari, also known as Al, had been an Independent Chairman of the Board of Baudax Bio Inc. since November 2019 until May 04, 2022. He has been the Chief Executive Officer at Agile Therapeut...


Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Alfred Altomari
Chairman13.8yrsUS$788.72k0.28%
$ 29.6k
Scott Coiante
CFO, Senior VP & Treasurerless than a yearUS$478.91k0.0012%
$ 120.9
Geoffrey Gilmore
Senior VP5.2yrsUS$554.69k0.15%
$ 15.3k
Paul Korner
Senior VP & Chief Medical Officer4yrsUS$537.78k0.049%
$ 5.1k
Robert Conway
Senior VP and Chief Corporate Planning & Supply Chain Officer6.8yrsUS$557.49k0.00042%
$ 43.8
Amy Welsh
Senior VP & Chief Commercial Officer2.6yrsVeri yokVeri yok

4.6yrs

Ortalama Görev Süresi

58yo

Ortalama Yaş

Deneyimli Yönetim: AGRX's management team is considered experienced (4.6 years average tenure).


Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Alfred Altomari
Chairman20.5yrsUS$788.72k0.28%
$ 29.6k
Sharon Surrey-Barbari
Independent Director4.2yrsUS$84.19k0.014%
$ 1.5k
John Hubbard
Independent Director9.8yrsUS$71.69k0.014%
$ 1.5k
Seth H. Fischer
Lead Independent Director8.1yrsUS$101.69k0.014%
$ 1.5k
Sandra Carson
Independent Director4.2yrsUS$61.69k0.014%
$ 1.5k
Josephine Torrente
Director2.8yrsUS$61.69k0.014%
$ 1.5k

6.1yrs

Ortalama Görev Süresi

68yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: AGRX's board of directors are considered experienced (6.1 years average tenure).